Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7296203 | 0.93 | NPC1 (0.60) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL24214280 | 0.92 | NPC1 (0.46) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL9138837 | 0.83 | NPC1 (0.49) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL826305 | 0.79 | KMT2A (0.47) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL31032250 | 0.79 | KMT2A (0.47) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL197915 | 0.79 | MAPT (0.54) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL2816695 | 0.77 | NPC1 (0.55) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL9351702 | 0.77 | FFAR4 (0.46) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL308377 | 0.77 | NPC1 (0.53) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL23588025 | 0.75 | ESR1 (0.46) | NPC1RAB9AMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3814332-B1 | PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2023-06-07 | — | — | EP | disclosed |
| EP-3814332-B1 | PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2023-06-07 | — | — | EP | disclosed |
| US-20210387954-A1 | OXADIAZOLES AS FUNGICIDES | PI INDUSTRIES LIMITED (IN) | 2021-12-16 | — | — | US | disclosed |
| US-20210387954-A1 | OXADIAZOLES AS FUNGICIDES | PI INDUSTRIES LIMITED (IN) | 2021-12-16 | — | — | US | disclosed |
| EP-3860982-A1 | OXADIAZOLES AS FUNGICIDES | PI Industries Ltd. (IN) | 2021-08-11 | — | — | EP | disclosed |
| CN-113195461-A | Novel oxadiazole compound | PI工业有限公司 | 2021-07-30 | — | — | CN | disclosed |
| EP-3814332-A1 | PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-05-05 | — | — | EP | disclosed |
| CN-112351978-A | Pesticidally active azole-amide compounds | 先正达参股股份有限公司 | 2021-02-09 | — | — | CN | disclosed |
| WO-2020070611-A1 | OXADIAZOLES AS FUNGICIDES | PI INDUSTRIES LTD (IN) | 2020-04-09 | — | — | WO | disclosed |
| WO-2020070611-A1 | OXADIAZOLES AS FUNGICIDES | PI INDUSTRIES LTD (IN) | 2020-04-09 | — | — | WO | disclosed |
| US-7667039-B2 | 1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitors | NOVARTIS AG (CH) | 2010-02-23 | — | — | US | disclosed |
| EP-2109364-A1 | NOVEL OXADIAZOLE COMPOUNDS | Abbott Laboratories (US) | 2009-10-21 | — | — | EP | disclosed |
| US-20080280876-A1 | Novel oxadiazole compounds | ABBVIE INC. | 2008-11-13 | — | — | US | disclosed |
| US-20080280876-A1 | Novel oxadiazole compounds | ABBVIE INC. | 2008-11-13 | — | — | US | disclosed |
| US-20080280876-A1 | Novel oxadiazole compounds | ABBVIE INC. | 2008-11-13 | — | — | US | disclosed |
| US-20080194579-A1 | 1,3-Dihydro-Imidazo [4,5-C] Quinolin-2-Ones as Lipid Kinase Inhibitors | NOVARTIS AG (CH) | 2008-08-14 | — | — | US | disclosed |
| WO-2008076356-A1 | NOVEL OXADIAZOLE COMPOUNDS | ABBOTT LABORATORIES (US) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008076356-A1 | NOVEL OXADIAZOLE COMPOUNDS | ABBOTT LABORATORIES (US) | 2008-06-26 | — | — | WO | disclosed |
| EP-1888578-A2 | IMIDAZOQUINOLINES AS LIPID KINASE INHIBITORS | Novartis AG (CH) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006122806-A2 | 1,3-DIHYDRO-IMIDAZO [4,5-C] QUINOLIN-2-ONES AS LIPID KINASE INHIBITORS | NOVARTIS AG (CH) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280876-A1 | Novel oxadiazole compounds | S1PR3, S1PR1, S1PR2 | NPC1 1268/4885RAB9A 2582/4885MEN1 2929/4885 |
| US-20080194579-A1 | 1,3-Dihydro-Imidazo [4,5-C] Quinolin-2-Ones as Lipid Kinase Inhibitors | PDPK1, PI4KA, PIP4K2A | NPC1 605/4885RAB9A 1474/4885MEN1 4266/4885 |
| US-20210387954-A1 | OXADIAZOLES AS FUNGICIDES | CYP1B1, CYP1A1, OXA1L | NPC1 2945/4885RAB9A 4214/4885MEN1 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.